Chemoinformaics analysis of Isorhamnetin-3-O-.beta.-D-glucopyranoside
| Molecular Weight | 476.434 | nRot | 5 |
| Heavy Atom Molecular Weight | 452.242 | nRig | 24 |
| Exact Molecular Weight | 476.132 | nRing | 4 |
| Solubility: LogS | -4.021 | nHRing | 1 |
| Solubility: LogP | 0.469 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 58 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 34 | No. of Aromatic Carbocycles | 2 |
| nHetero | 11 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 23 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 11 | No. of Arom Bond | 17 |
| nHA | 11 | APOL | 63.235 |
| nHD | 7 | BPOL | 30.153 |
| QED | 0.27 |
| Synth | 4.109 |
| Natural Product Likeliness | 2.082 |
| NR-PPAR-gamma | 0.907 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.004 |
| Pgp-sub | 0.822 |
| HIA | 0.762 |
| CACO-2 | -6.002 |
| MDCK | 0.0000151 |
| BBB | 0.038 |
| PPB | 0.867155 |
| VDSS | 1.014 |
| FU | 0.137676 |
| CYP1A2-inh | 0.074 |
| CYP1A2-sub | 0.122 |
| CYP2c19-inh | 0.013 |
| CYP2c19-sub | 0.063 |
| CYP2c9-inh | 0.017 |
| CYP2c9-sub | 0.7 |
| CYP2d6-inh | 0.148 |
| CYP2d6-sub | 0.225 |
| CYP3a4-inh | 0.063 |
| CYP3a4-sub | 0.068 |
| CL | 9.105 |
| T12 | 0.842 |
| hERG | 0.028 |
| Ames | 0.533 |
| ROA | 0.078 |
| SkinSen | 0.072 |
| Carcinogencity | 0.019 |
| EI | 0.013 |
| Respiratory | 0.034 |
| NR-Aromatase | 0.888 |
| Antiviral | Yes |
| Prediction | 0.925521 |